One thousand SARS-CoV-2 antibody structures reveal convergent binding and near-universal immune escape
Cell Systems · 2026
DOI: 10.1016/j.cels.2025.101452 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Systems, 2026. Verfasst von Zirui Feng und 7 weiteren Autor:innen. Beteiligte Einrichtung: Center of Protein Engineering and Therapeutics, Department of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 10029, …. Hauptthemen laut MEDLINE: SARS-CoV-2, Antibodies, Viral, Immune Evasion, COVID-19. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 100 Literaturangaben. Gefördert von: Icahn School of Medicine at Mount Sinai, NIH, National Institute of Allergy and Infectious Diseases.
Abstract (Originalsprache)
Understanding antibody recognition and adaptation to viral evolution is central to vaccine and therapeutic development. Over 1,100 SARS-CoV-2 antibody structures have been resolved, marking the largest structural biology effort for a single pathogen. We present a comprehensive analysis of this landmark dataset to investigate the principles of antibody recognition and immune escape. Human immunoglobulins and camelid single-chain antibodies dominate, collectively mapping 99% of the receptor-binding domain. Despite remarkable sequence and conformational diversity, antibodies exhibit convergence in their paratope structures, revealing evolutionary constraints in epitope selection. Analyses reveal near-universal immune escape of antibodies, including all clinical monoclonals, by advanced variants such as KP3.1.1. On average, over one-third of antibody epitope residues are mutated. These findings support pervasive immune escape, underscoring the need to effectively leverage multi-epitope-targeting strategies to achieve durable immunity. To support community accessibility, we developed an interactive web server for visualization and analysis of antibody-antigen complexes and mutational data.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center of Protein Engineering and Therapeutics, Department of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
- Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA; Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
- School of Computer Science and Engineering, The Hebrew University of Jerusalem, Jerusalem, Israel.
- Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA; Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA; Department…
- Center of Protein Engineering and Therapeutics, Department of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA. Electronic address: wally.yis@gmail.com.
Förderung
- Icahn School of Medicine at Mount Sinai
- NIH
- National Institute of Allergy and Infectious Diseases
Zitieren
APA
Feng, Z., Sang, Z., Xiang, Y., Escalera, A., Weshler, A., Schneidman-Duhovny, D., García-Sastre, A., & Shi, Y. (2026). One thousand SARS-CoV-2 antibody structures reveal convergent binding and near-universal immune escape. Cell Systems. https://doi.org/10.1016/j.cels.2025.101452
Vancouver
Feng Z, Sang Z, Xiang Y, Escalera A, Weshler A, Schneidman-Duhovny D, et al. One thousand SARS-CoV-2 antibody structures reveal convergent binding and near-universal immune escape. Cell Systems. 2026. doi:10.1016/j.cels.2025.101452
BibTeX
@article{Feng2026,
author = {Feng, Zirui and Sang, Zhe and Xiang, Yufei and Escalera, Alba and Weshler, Adi and Schneidman-Duhovny, Dina and García-Sastre, Adolfo and Shi, Yi},
title = {One thousand SARS-CoV-2 antibody structures reveal convergent binding and near-universal immune escape},
journal = {Cell Systems},
year = {2026},
doi = {10.1016/j.cels.2025.101452}
}
EUVIMED